Please Wait
Applying Filters...
menu
    • menu
    Mix GIF-PSE
    News
    Leqembi-Iqlik PDUFA Date Updated To August 24 In US

    09 May 2026

    // PR NEWSWIRE

    Atara, Pierre's Cell Therapy to Get Another Shot at FDA Approval

    09 May 2026

    // BIOSPACE

    GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs

    09 May 2026

    // PR NEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    FCE Pharma

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued
    Menu

    Symbiotica Speciality Ingredients Sdn Bhd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2026

    read-more

      https://www.pharmacompass.com/pdf/party/content/symbiotica-speciality-ingredients-sdn-bhd-party-content-95204.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/symbiotica-party-content-13740.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Every year, the US Food and Drug Administration (FDA) publishes the user fee amounts it will collect from manufacturers of pharmaceuticals, generic drugs, biosimilars and medical devices in the coming financial year. The fee for fiscal year 2025 under the Generic Drug User Fee Act (GDUFA) was published on July 31, 2024.The GDUFA, established in 2012, authorizes FDA to assess and collect fees from drug manufacturers to expedite the delivery of safe, high-quality, and affordable generic drugs to the American public.The FDA’s facility payments list under GDUFA reveals that as of November 14, 2024, 1,397 facilities had paid their registration fees for financial year 2025. Of these facilities, 707 or 50.6 percent are active pharmaceutical ingredients (API) facilities, 405 or 29 percent are finished dosage forms (FDF) facilities, 69 (4.9 percent) are facilities that produce both APIs and FDFs, and 216 (15.5 percent) are contract manufacturing services (CMO) sites.Teva Pharmaceuticals, with 29 facility registrations, led the list of companies, followed by Aurobindo Pharma, Sun Pharma, and Dr. Reddy's Laboratories. Fiscal year Facility Registrations 2016 1,425 2017 1,442 2018 1,269 2019 1,286 2020 1,300 2021 1,340 2022 1,385 2023 1,394 2024 1,447 2025 1,397  Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available)India continues to lead with 396 facilities, US and China follow India maintains its dominance in total facility registrations with the FDA, registering 396 facilities for FY2025. This includes 214 API facilities, 135 FDF facilities, 21 facilities engaged in both API and FDF activities, and 26 CMO facilities.The United States holds the second position with 328 facilities, while China strengthened its third position with 197 facilities.With 214 API facilities, India continues to have the largest share of API manufacturing sites, outmatching the combined total of China (128) and the US (83), which together account for 211 facilities. Among European manufacturers, Italy leads with 59 API manufacturing sites, followed by Spain (30) and Germany (25).The US has maintained its lead in FDF facilities with 143 sites, followed closely by India with 135 sites and China with 45 sites. Country API FDF Both CMO Total India 214 135 21 26 396 US 83 143 13 89 328 China 128 45 12 12 197 Italy 59 3 2 19 83 Germany 25 4 1 15 45 Spain 30 9 1 4 44 Canada 7 17   13 37 Taiwan 9 6 5 4 24 Switzerland 15 4   4 23 France 16     6 22 Japan 18   1   19 United Kingdom 12 1   2 15 Mexico 9 1   1 11 Ireland 5 5   1 11   Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) GDUFA III user fee rates increase across categories for FY25The GDUFA, which was reauthorized on September 30, 2022 (as GDUFA III), continues with provisions that will last until September 30, 2027. In July 2024, the FDA published updated user fee rates for FY2025.The facility fees have seen increases across all categories. API facility fees increased by 3 percent for domestic sites (to US$ 41,580) and 2 percent for foreign sites (to US$ 56,580). FDF facility fees rose by 5 percent for both domestic (to US$ 231,952) and foreign sites (to US$ 246,952). CMO facility fees increased by 5 percent for domestic sites (to US$ 55,668) and 4 percent for foreign sites (to US$ 70,668).Additionally, the fee for large-, medium- and small-sized drug applicants has increased by over 9 percent, compared to the 7 percent increase seen in 2023. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) China leads new facility registrations as FDA records 41 new units in FY25Out of the total 1,397 facilities registered for FY2025, 41 were new registrations (going by Facility FDA Establishment Identifier numbers). China led the way with 13 new facilities, followed closely by India with 11 new facilities, while the US secured the third position with eight new facilities.The new registrations included 15 API facilities, 13 CMO facilities, 12 FDF facilities, and one facility engaged in both API and FDF activities. Chinese companies dominated the new FDF registrations with six facilities: Chengdu Shuode Pharma, Chengdu Suncadia Medicine, Cipla (Jiangsu), GE Healthcare (Shanghai), Luoxin Aurovitas Pharma (Chengdu), and Zhejiang Xianju Pharma.India added two new FDF facilities through Eugia Steriles and Zydus Pharma. Malaysia registered two FDF facilities through Novugen Pharma and Novugen Oncology, while Turkey’s Insud Pharma subsidiary Exeltis and US’ RK Pharma registered one FDF facility each.The 13 new CMO facilities included, Acme Generics, Emcure, Esjay Pharma, Fordoz Pharma, Fourrts Laboratories, Laboratoires KABS, PharmaMax, Quality Packaging Specialists International, Ritsa Pharma, Shanghai Aucyun Pharma, Sichuan Huiyu Pharma, Taejoon Pharm, and Tubilux Pharma.In the API category, the 15 new registrations included Acharya Chemicals, Hainan Poly Pharma, CBL Patras, EUROAPI, Hybio Pharma, Medilux Laboratories, Metrochem API, Purolite, Chengdu Easton Biopharma, Sionc Pharma, Smithfield Bioscience, Xttrium Laboratories, Zhejiang Hengkang Pharma, Moehs Iberica and Shilpa Pharma. Armstrong Pharmaceuticals registered the sole facility for both APIs and FDFs.So far, 92 facilities have not renewed their registration. Among these was a facility owned by Sandoz subsidiary Eon Labs in Wilson, North Carolina (US), which is permanently closed. In fact, the geographical distribution of non-renewals shows that 30 facilities were from the US, while India and China accounted for 14 and nine non-renewals respectively. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) Our viewThe FY 2025 GDUFA facility registration data indicates a continued strong presence of Indian manufacturers in the US generic drug market, particularly in API production. However, China's leadership in new facility registrations, especially in FDF manufacturing, suggests that the global generic drug supply chain landscape may evolve considerably in the coming years. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 16058

    https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities

    #PharmaFlow by PHARMACOMPASS
    21 Nov 2024
    Share Share
    Contact Symbiotica and get a quotation

    Symbiotica is a supplier offers 67 products (APIs, Excipients or Intermediates).

    Find Mometasone Furoate bulk with DMF, CEP, JDMF, WC offered by Symbiotica

    Find Betamethasone Dipropionate bulk with DMF, CEP, WC offered by Symbiotica

    Find Clobetasol Propionate bulk with DMF, CEP, WC offered by Symbiotica

    Find Dexamethasone Sodium Phosphate bulk with DMF, CEP, WC offered by Symbiotica

    Find Exemestane bulk with DMF, CEP, WC offered by Symbiotica

    Find Betamethasone Sodium Phosphate bulk with CEP, WC offered by Symbiotica

    Find Betamethasone Valerate bulk with CEP, WC offered by Symbiotica

    Find Clobetasone Butyrate bulk with JDMF, WC offered by Symbiotica

    Find Halobetasol bulk with DMF, WC offered by Symbiotica

    Find Hydrocortisone Valerate bulk with DMF, WC offered by Symbiotica

    Find Prednicarbate bulk with CEP, WC offered by Symbiotica

    Find Prednisolone Acetate bulk with CEP, WC offered by Symbiotica

    Find Testosterone Propionate bulk with CEP, WC offered by Symbiotica

    Find Tibolone bulk with CEP, WC offered by Symbiotica

    Find Beclomethasone Dipropionate bulk with WC offered by Symbiotica

    Find Betamethasone Acetate bulk with WC offered by Symbiotica

    Find Budesonide bulk with WC offered by Symbiotica

    Find Clostebol Acetate bulk with WC offered by Symbiotica

    Find Deflazacort bulk with WC offered by Symbiotica

    Find Desogestrel bulk with WC offered by Symbiotica

    Find Desonide bulk with WC offered by Symbiotica

    Find Dexamethasone bulk with WC offered by Symbiotica

    Find Dexamethasone Sodium Phosphate bulk with WC offered by Symbiotica

    Find Diflorasone bulk with WC offered by Symbiotica

    Find Drospirenone bulk with WC offered by Symbiotica

    Find Flavoxate bulk with WC offered by Symbiotica

    Find Flumethasone Pivalate bulk with WC offered by Symbiotica

    Find Fluocinolone Acetonide bulk with WC offered by Symbiotica

    Find Fluocinonide bulk with WC offered by Symbiotica

    Find Fluticasone Propionate bulk with WC offered by Symbiotica

    Find Hydrocortisone bulk with WC offered by Symbiotica

    Find Hydrocortisone Butyrate bulk with WC offered by Symbiotica

    Find Methylprednisolone Aceponate bulk with WC offered by Symbiotica

    Find Methylprednisolone Acetate bulk with WC offered by Symbiotica

    Find Methylprednisolone Hemisuccinate bulk with WC offered by Symbiotica

    Find Mometasone Furoate bulk with CEP offered by Symbiotica

    Find Pinaverium Bromide bulk with WC offered by Symbiotica

    Find Polyestradiol Phosphate bulk with WC offered by Symbiotica

    Find Prednisolone bulk with WC offered by Symbiotica

    Find Prednisolone Sodium Metasulfobenzoate bulk with WC offered by Symbiotica

    Find Prednisolone Sodium Phosphate bulk with WC offered by Symbiotica

    Find Prednisolone Valerate Acetate bulk with WC offered by Symbiotica

    Find Testosterone bulk with WC offered by Symbiotica

    Find Testosterone Undecanoate bulk with WC offered by Symbiotica

    Find Triamcinolone Acetonide bulk with WC offered by Symbiotica

    Find Triamcinolone Diacetate bulk with WC offered by Symbiotica

    Find Triamcinolone Hexacetonide bulk with WC offered by Symbiotica

    Find Trilostane bulk with WC offered by Symbiotica

    Find Betamethasone bulk offered by Symbiotica

    Find Boldenone Undecylenate bulk offered by Symbiotica

    Find Desoximetasone bulk offered by Symbiotica

    Find Dexamethasone Palmitate bulk offered by Symbiotica

    Find Dexamethasone Sodium Phosphate bulk offered by Symbiotica

    Find Diflucortolone Valerate bulk offered by Symbiotica

    Find Difluprednate bulk offered by Symbiotica

    Find Hydrocortisone Valerate bulk offered by Symbiotica

    Find Methylprednisolone bulk offered by Symbiotica

    Find Methylprednisolone Acetate bulk offered by Symbiotica

    Find Nandrolone Decanoate bulk offered by Symbiotica

    Find Nandrolone Phenpropionate bulk offered by Symbiotica

    Find Norethisterone bulk offered by Symbiotica

    Find Norethisterone Acetate bulk offered by Symbiotica

    Find Norethisterone Enanthate bulk offered by Symbiotica

    Find Testosterone Cypionate bulk offered by Symbiotica

    Find Testosterone Enanthate bulk offered by Symbiotica

    Find Thyroxine bulk offered by Symbiotica

    Find Trilostane bulk offered by Symbiotica

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.